Published in Clin Chem on February 26, 2009
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. J Oncol (2009) 1.84
MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum (2010) 1.78
High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. Proc Natl Acad Sci U S A (2010) 1.78
Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb Perspect Biol (2010) 1.64
miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem (2011) 1.63
MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res (2011) 1.57
Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer (2014) 1.56
microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol (2011) 1.50
Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One (2011) 1.48
Multiplexed detection and label-free quantitation of microRNAs using arrays of silicon photonic microring resonators. Angew Chem Int Ed Engl (2010) 1.43
Novel functions for small RNA molecules. Curr Opin Mol Ther (2009) 1.39
Microrna profiling analysis of differences between the melanoma of young adults and older adults. J Transl Med (2010) 1.39
Interplay of microRNAs, transcription factors and target genes: linking dynamic expression changes to function. Nucleic Acids Res (2013) 1.38
Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res (2010) 1.36
MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum (2011) 1.31
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One (2012) 1.31
Exosome mimetics: a novel class of drug delivery systems. Int J Nanomedicine (2012) 1.27
MicroRNAs in ovarian carcinomas. Endocr Relat Cancer (2010) 1.25
MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS One (2013) 1.23
Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology (2011) 1.22
MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res (2011) 1.21
Predictive and prognostic molecular markers for cancer medicine. Ther Adv Med Oncol (2010) 1.18
Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer. J Gastroenterol (2011) 1.16
MicroRNAs determine human intestinal epithelial cell fate. Differentiation (2010) 1.16
MicroRNA-199a* regulates the expression of cyclooxygenase-2 in human chondrocytes. Ann Rheum Dis (2012) 1.14
Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index. World J Surg (2012) 1.14
MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells. PLoS One (2012) 1.13
Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLoS One (2011) 1.12
Roles of microRNA on cancer cell metabolism. J Transl Med (2012) 1.11
MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PLoS One (2012) 1.11
MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One (2012) 1.11
Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med (2010) 1.10
Cancer biomarkers: are we ready for the prime time? Cancers (Basel) (2010) 1.10
Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA Cell Biol (2011) 1.09
MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer (2010) 1.09
MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma. Acta Pharmacol Sin (2011) 1.08
Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription. BMC Genomics (2011) 1.08
Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep (2015) 1.06
MicroRNA binding site polymorphisms as biomarkers of cancer risk. Expert Rev Mol Diagn (2010) 1.06
MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol (2009) 1.02
Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach. PLoS One (2011) 1.02
MicroRNA Control of Invasion and Metastasis Pathways. Front Genet (2011) 1.02
The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients. Br J Cancer (2013) 1.01
A microRNA signature associated with early recurrence in breast cancer. PLoS One (2014) 1.00
MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region. Nucleic Acids Res (2011) 0.99
Differential microRNA expression and virulence of avian, 1918 reassortant, and reconstructed 1918 influenza A viruses. Virology (2011) 0.99
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy. J Ovarian Res (2012) 0.98
Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells. Int J Cancer (2013) 0.97
MicroRNA-184 modulates canonical Wnt signaling through the regulation of frizzled-7 expression in the retina with ischemia-induced neovascularization. FEBS Lett (2015) 0.97
Down-regulation of miR-497 is associated with poor prognosis in renal cancer. Int J Clin Exp Pathol (2015) 0.96
A genetic variant in pre-miR-27a is associated with a reduced renal cell cancer risk in a Chinese population. PLoS One (2012) 0.96
Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction. J Thorac Dis (2015) 0.96
The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma. Clin Exp Metastasis (2014) 0.95
MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation. BMC Cancer (2013) 0.95
MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer. J Transl Med (2015) 0.94
Unbiased approaches to biomarker discovery in neurodegenerative diseases. Neuron (2014) 0.93
miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma. Oncotarget (2015) 0.93
MicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancer. PLoS One (2015) 0.93
MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis. Gastric Cancer (2014) 0.93
Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma. J Transl Med (2016) 0.92
Minireview: The roles of small RNA pathways in reproductive medicine. Mol Endocrinol (2011) 0.92
MicroRNAs as Novel Biomarkers in Colorectal Cancer. Front Genet (2012) 0.92
MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model. Invest Ophthalmol Vis Sci (2013) 0.92
Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs. PLoS One (2014) 0.92
Heavy ions, radioprotectors and genomic instability: implications for human space exploration. Radiat Environ Biophys (2009) 0.91
Roles of host and viral microRNAs in human cytomegalovirus biology. Virus Res (2010) 0.91
MicroRNA-23a promotes myelination in the central nervous system. Proc Natl Acad Sci U S A (2013) 0.90
Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways. J Oncol (2012) 0.88
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastasis Rev (2015) 0.88
A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population. PLoS One (2013) 0.86
MicroRNAs as putative mediators of treatment response in prostate cancer. Nat Rev Urol (2012) 0.86
AB209630, a long non-coding RNA decreased expression in hypopharyngeal squamous cell carcinoma, influences proliferation, invasion, metastasis, and survival. Oncotarget (2016) 0.85
Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.85
MicroRNA profile in very young women with breast cancer. BMC Cancer (2014) 0.85
Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion. Cancer Res Treat (2014) 0.84
A new plasmid-based microRNA inhibitor system that inhibits microRNA families in transgenic mice and cells: a potential new therapeutic reagent. Gene Ther (2016) 0.84
MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin. PLoS One (2015) 0.84
High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells. World J Gastroenterol (2012) 0.84
An integrative meta-analysis of microRNAs in hepatocellular carcinoma. Genomics Proteomics Bioinformatics (2013) 0.84
microRNA expression and biogenesis in cellular response to ionizing radiation. DNA Cell Biol (2014) 0.84
Recent Advance in Biosensors for microRNAs Detection in Cancer. Cancers (Basel) (2011) 0.84
The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review. Front Microbiol (2014) 0.84
Current challenges in development of differentially expressed and prognostic prostate cancer biomarkers. Prostate Cancer (2012) 0.84
Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis. PLoS One (2015) 0.84
Hormonal regulation of microRNA expression in steroid producing cells of the ovary, testis and adrenal gland. PLoS One (2013) 0.83
Functional analysis of microRNA and transcription factor synergistic regulatory network based on identifying regulatory motifs in non-small cell lung cancer. BMC Syst Biol (2013) 0.82
miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature Review. J Dent (Shiraz) (2016) 0.82
miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients. J Mol Cell Cardiol (2013) 0.82
Tumor suppressor role of microRNA-1296 in triple-negative breast cancer. Oncotarget (2016) 0.82
Colonic miRNA expression/secretion, regulated by intestinal epithelial PepT1, plays an important role in cell-to-cell communication during colitis. PLoS One (2014) 0.82
Sequencing and validation of housekeeping genes for quantitative real-time PCR during the gonadotrophic cycle of Diploptera punctata. BMC Res Notes (2013) 0.81
Poor ovarian response in women undergoing in vitro fertilization is associated with altered microRNA expression in cumulus cells. Fertil Steril (2015) 0.81
Antitumor activity of miR-1280 in melanoma by regulation of Src. Mol Ther (2014) 0.81
MicroRNA-23b Inhibits the Proliferation and Migration of Heat-Denatured Fibroblasts by Targeting Smad3. PLoS One (2015) 0.81
Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis. Am J Cancer Res (2014) 0.81
Research of the methylation status of miR-124a gene promoter among rheumatoid arthritis patients. Clin Dev Immunol (2013) 0.81
An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma. J Exp Clin Cancer Res (2012) 0.81
MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer. World J Surg Oncol (2015) 0.80
Klotho: a novel biomarker for cancer. J Cancer Res Clin Oncol (2014) 0.80
MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. Clin Chem (2010) 1.95
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem (2008) 1.87
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models. Cancer Prev Res (Phila) (2011) 1.61
Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A (2007) 1.61
The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem (2010) 1.37
Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations. Clin Chem Lab Med (2014) 1.34
The additive blood pressure lowering effects of exercise intensity on post-exercise hypotension. Am Heart J (2010) 1.24
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients. Cancer Treat Rev (2013) 1.23
Characterization of "Candidatus piscichlamydia salmonis" (order Chlamydiales), a chlamydia-like bacterium associated with epitheliocystis in farmed Atlantic salmon (Salmo salar). J Clin Microbiol (2004) 1.19
Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults. Am J Gastroenterol (2013) 1.08
MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Cancer Genet (2013) 1.08
RAAS polymorphisms alter the acute blood pressure response to aerobic exercise among men with hypertension. Eur J Appl Physiol (2006) 1.04
COMT Val158Met Genotype and Individual Differences in Executive Function in Healthy Adults. J Int Neuropsychol Soc (2010) 1.01
Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study. Brain Inj (2008) 1.01
[MicroRNAs: novel biomarkers for human cancer]. Ann Biol Clin (Paris) (2010) 0.99
Automated high multiplex qPCR platform for simultaneous detection and quantification of multiple nucleic acid targets. Biotechniques (2012) 0.99
Endothelial nitric oxide gene polymorphisms, nitric oxide production and coronary artery disease risk in a South Indian population. Exp Mol Pathol (2010) 0.94
Genetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes. Am J Med Genet B Neuropsychiatr Genet (2010) 0.94
BRCA1 and BRCA2 mutation screening using SmartCycler II high-resolution melt curve analysis. Arch Pathol Lab Med (2006) 0.94
A comprehensive assay for CFTR mutational analysis using next-generation sequencing. Clin Chem (2013) 0.94
Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues. J Clin Oncol (2011) 0.94
Multilaboratory evaluation of real-time PCR tests for hepatitis B virus DNA quantification. J Clin Microbiol (2011) 0.93
Dietary calcium intake and renin angiotensin system polymorphisms alter the blood pressure response to aerobic exercise: a randomized control design. Nutr Metab (Lond) (2007) 0.91
Apolipoprotein E genotype and changes in serum lipids and maximal oxygen uptake with exercise training. Metabolism (2004) 0.90
Use of a linear array for the detection of human papillomavirus genotypes in head and neck cancer. Arch Pathol Lab Med (2010) 0.89
Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training. Atherosclerosis (2005) 0.88
Development of an integrated assay for detection of BCR-ABL RNA. Clin Chem (2007) 0.88
Prevalence of MTHFR gene polymorphisms (C677T and A1298C) among Tamilians. Exp Mol Pathol (2004) 0.87
Lynch syndrome presenting as endometrial cancer. Clin Chem (2013) 0.87
Primary melanoma of the spinal cord: a case report, molecular footprint, and review of the literature. J Clin Oncol (2011) 0.87
Cystic fibrosis. Am J Clin Pathol (2003) 0.87
Molecular mechanisms of human carcinogenesis. EXS (2006) 0.86
Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury. J Neurotrauma (2012) 0.86
Automation of genomic DNA isolation from formalin-fixed, paraffin-embedded tissues. Pathol Res Pract (2012) 0.85
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psychooncology (2014) 0.84
Evaluation of the Nanosphere Verigene System and the Verigene F5/F2/MTHFR Nucleic Acid Tests. Exp Mol Pathol (2009) 0.84
The endothelial nitric oxide synthase -786 T>C polymorphism and the exercise-induced blood pressure and nitric oxide responses among men with elevated blood pressure. Atherosclerosis (2008) 0.84
Detection of the FCGR3a polymorphism using a real-time polymerase chain reaction assay. Cancer Genet (2013) 0.83
Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung. Exp Mol Pathol (2008) 0.83
Alu profiling of primary and metastatic nonsmall cell lung cancer. Exp Mol Pathol (2003) 0.83
The effect of apolipoprotein E genotype on serum lipoprotein particle response to exercise. Atherosclerosis (2006) 0.83
Prevalence of the Factor V G1691A and the Factor II/prothrombin G20210A gene polymorphisms among Tamilians. Exp Mol Pathol (2005) 0.82
Interactive effects of APOE haplotype, sex, and exercise on postheparin plasma lipase activities. J Appl Physiol (1985) (2011) 0.81
Angiotensin-converting enzyme genotype and adherence to aerobic exercise training. Prev Cardiol (2006) 0.81
Quantitative assessment of the BCR-ABL transcript using the Cepheid Xpert BCR-ABL Monitor assay. Arch Pathol Lab Med (2007) 0.81
Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases. Diagn Cytopathol (2011) 0.81
Search for evidence of recurring or persistent viruses in Crohn's disease. APMIS (2007) 0.80
Real time PCR detection of the PI*Z and PI*S mutations associated with alpha-1 antitrypsin deficiency. Am J Transl Res (2009) 0.80
Warfarin genotyping using three different platforms. Am J Transl Res (2010) 0.80
Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther (2013) 0.80
Establishment of a CYP2C19 genotyping assay for clinical use. Am J Clin Pathol (2013) 0.80
The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine. Am J Pathol (2013) 0.80
Merkel cell polyomavirus and extrapulmonary small cell carcinoma. Oncol Lett (2013) 0.80
The alpha-adducin Gly460Trp polymorphism and the antihypertensive effects of exercise among men with high blood pressure. Clin Sci (Lond) (2007) 0.80
A multiplex real-time polymerase chain reaction assay with two internal controls for the detection of Brucella species in tissues, blood, and feces from marine mammals. J Vet Diagn Invest (2013) 0.80
Correlates of endothelial function and the peak systolic blood pressure response to a graded maximal exercise test. Atherosclerosis (2012) 0.79
Molecular diagnostics: parallels between infectious disease and emerging oncology testing. Expert Opin Med Diagn (2010) 0.79
The human epidermal growth factor receptor 2 (HER2). Clin Chem Lab Med (2011) 0.79
Effective quality management practices in routine clinical next-generation sequencing. Clin Chem Lab Med (2016) 0.79
Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolism. Clin Chim Acta (2006) 0.79
Certification in molecular pathology in the United States (Training and Education Committee, The Association for Molecular Pathology). J Mol Diagn (2002) 0.78
A comparison of the genetic and clinical profile of men that respond and do not respond to the immediate antihypertensive effects of aerobic exercise. Appl Clin Genet (2008) 0.78
MTHFR Gene polymorphisms, B-vitamins and hyperhomocystinemia in young and middle-aged acute myocardial infarction patients. Exp Mol Pathol (2007) 0.78
Primary carcinoid tumor of the common hepatic duct: A rare case with immunohistochemical and molecular findings. Oncol Rep (2005) 0.78
Validation of a solid-phase electrochemical array for genotyping hepatitis C virus. Exp Mol Pathol (2013) 0.78
The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells. Melanoma Res (2016) 0.77
Cystic fibrosis mutation analysis: how many is enough? Genet Med (2004) 0.77
MicroRNAs in chronic lymphocytic leukemia. Exp Mol Pathol (2010) 0.77
Parameters involved in the conversion of real-time PCR assays from the ABI prism 7700 to the Cepheid SmartCycler II. Clin Biochem (2005) 0.77
The practical application of chimerism analyses in allogeneic stem cell transplant recipients: blood chimerism is equivalent to marrow chimerism. Exp Mol Pathol (2012) 0.77
A validation study of a new molecular diagnostic assay: the Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes. Exp Mol Pathol (2009) 0.77
Correlation of polypoid colorectal adenocarcinoma with pre-existing adenomatous polyps and KRAS mutation. Cancer Genet (2011) 0.76
Recent advances in microRNA-mediated gene regulation in chronic lymphocytic leukemia. Clin Biochem (2013) 0.76
Democratizing molecular diagnostics for the developing world. Am J Clin Pathol (2014) 0.76
Evaluating the thermostability of commercial fast real-time PCR master mixes. Exp Mol Pathol (2012) 0.76
KRAS mutation detection: a new look at an old gene. Clin Chem (2010) 0.76
Successful retreatment with chemoradiotherapy for local recurrence of pancreatic adenocarcinoma after neoadjuvant therapy and pancreaticoduodenectomy. Gastrointest Cancer Res (2013) 0.75
Intravascular lymphoma as a recurrence of testicular Non-Hodgkin's lymphoma confirmed by polymerase chain reaction. Am J Hematol (2008) 0.75
DNA STAT: the ability to perform clinical analysis in real time. Expert Rev Mol Diagn (2005) 0.75
Molecular oncology: current trends in diagnostics. Future Oncol (2008) 0.75
Real-time polymerase chain reaction and laser capture microdissection for the diagnosis of BK virus infection in renal allografts. Am J Clin Pathol (2005) 0.75
Detection of the C282Y and H63D polymorphisms associated with hereditary hemochromatosis using the ABI 7500 fast real time PCR platform. Diagn Mol Pathol (2007) 0.75
Pharmacogenetics: where are we with respect to personalized medicine? Expert Opin Med Diagn (2007) 0.75
A novel mutation in exon 5 of the ALAS2 gene results in X-linked sideroblastic anemia. Clin Chim Acta (2002) 0.75
KRAS detection in colonic tumors by DNA extraction from FTA paper: the molecular touch-prep. Diagn Mol Pathol (2011) 0.75
Polyomavirus infection of the urinary tract presenting as hemorrhagic cystitis in an immunocompetent five-year-old boy. Diagn Cytopathol (2008) 0.75
Evaluation of a BK virus real-time PCR assay designed using novel bioinformatics technology. Exp Mol Pathol (2010) 0.75
Validation of a CYP2D6 genotyping panel on the NanoChip Molecular Biology Workstation. Clin Chem (2007) 0.75
A clinical PCR fragment analysis assay for TA repeat sizing in the UGT1A1 promoter region. Clin Chim Acta (2013) 0.75
Fatal relapse of ANCA-associated glomerulonephritis triggered by successive Epstein-Barr and varicella zoster virus infections. Am J Kidney Dis (2006) 0.75
Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center. Arch Pathol Lab Med (2016) 0.75
Condylomata of the pannus in 3 obese patients: a new location for a common disease. Arch Dermatol (2010) 0.75
KRAS testing in clinical laboratory: optimizing targeted therapy. Cancer Genomics Proteomics (2012) 0.75
The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. Pancreas (2014) 0.75